Current evidence and practical recommendations for the use of oral semaglutide in people with T2D Glycemic benefits of oral semaglutide Use of oral semaglutide in drug-nave people with T2D The PIONEER 1 trial established the efficacy and safety of oral semaglutide in drug-nave adults with T2D
Weight Management During Pregnancy After Stopping Tirzepatide After discontinuing tirzepatide, weight regain is common during pregnancy as appetite regulation normalizes and caloric needs increase for fetal development
More and more patients seem to favor oral therapy, partly due to it causes less discomfort and keeps the routine easier to stick with
A federal law establishing minimum transparency standards that apply to all employer drug benefit plans including self-insured plans would close the state regulation gap
Its assets include EL-22 and EL-32, product candidates targeting myostatin and activin A pathways for potential muscle preservation applications in patients undergoing GLP-1 receptor agonist weight loss treatment
Activating your body's natural GLP-1 (glucagon-like peptide-1) pathways is about curbing cravings and supporting overall metabolic health, energy balance, and long-term well-being
